AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma

Research output: Contribution to journal › Scientific review › peer-review

30 Citations (Scopus)

1 results

Finished
SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)
Vanderkerken, K. (Administrative Promotor), Thielemans, K. (Administrative Promotor), Vanderkerken, K. (Co-Promotor) & Breckpot, K. (Co-Promotor)
1/11/17 → 31/10/24
Project: Fundamental